Skip to main content
. 2019 Nov 15;20(22):5731. doi: 10.3390/ijms20225731
CTL cytotoxic T lymphocyte
CTLA-4 cytotoxic T lymphocyte antigen-4
PD-1 programmed death 1 receptor
PD-L1 programmed death ligand 1
irAE immune related adverse effect
NSCLC non-small cell lung cancer